| Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|
| Survival | = | 66.5 | % |
| Survival | = | 69.1 | % |
| Survival | = | 69.9 | % |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0000000311 uM | Activity at 0.0000000880 uM | Activity at 0.0000001756 uM | Activity at 0.0000004972 uM | Activity at 0.0000014063 uM | Activity at 0.0000028127 uM | Activity at 0.0000079555 uM | Activity at 0.0000225014 uM | Activity at 0.0000450029 uM | Activity at 0.0001299230 uM | Activity at 0.0003002708 uM | Activity at 0.0008965874 uM | Activity at 0.00268 uM | Activity at 0.00700 uM | Activity at 0.016 uM | Activity at 0.032 uM | Activity at 0.076 uM | Activity at 0.219 uM | Activity at 0.631 uM | Activity at 1.728 uM | Activity at 3.886 uM | Activity at 8.589 uM | Activity at 17.80 uM | Activity at 49.20 uM | Activity at 107.3 uM | Activity at 231.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inactive | 0 | 4.9549 | 0.4153 | -14.5146 | 1 | 4 | 0 0 0 0 1 | 4.685 | -8.5335 | 0.7807 | 11.3474 | -12.5122 | 4.685 | QC'd by "Microsource" | ||||||||||||||||||||||||||
| Activator | 12.5893 | 29.2705 | 0 | Single point of activity | -4.9 | 4.9549 | 0.9612 | 31 | 1.7295 | 3 | 0 0 0 0 0 | 30.9001 | -1.4754 | 1.0166 | 5.6243 | 6.6083 | 30.9001 | QC'd by "Microsource" | ||||||||||||||||||||||
| Activator | 8.9125 | 65.9699 | 0 | Partial curve; partial efficacy | -5.05 | 0.6 | 0.9478 | 60.7629 | -5.207 | 2.2 | 0 0 0 0 0 | 46.0767 | -2.3225 | 0.7459 | 18.7564 | 22.5194 | 46.0767 | QC'd by "Microsource" | ||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.3508 | -5.4241 | 12 | 4 | 0 0 0 0 0 | 2.824 | 6.9985 | -6.3081 | -17.4367 | -1.0266 | 2.824 | QC'd by "Microsource" | ||||||||||||||||||||||||||
| Inactive | 0 | 4.095 | 0.8518 | -20.6942 | -4.8432 | 4 | 1 0 0 0 0 | -16.9639 | -25.916 | -5.286 | -19.6983 | -24.7451 | -16.9639 | QC'd by "Microsource" | ||||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.8518 | -16.2964 | 1.5 | 4 | 0 0 0 0 1 | 4.1206 | 1.8961 | -0.6171 | -21.497 | -11.4248 | 4.1206 | QC'd by "Microsource" | ||||||||||||||||||||||||||
| Activator | 2.2387 | 83.6659 | 0 | Partial curve; partial efficacy; poor fit | -5.65 | 0.5 | 0.8806 | 54.0974 | -29.5685 | 2.4 | 0 0 0 0 0 | 44.3794 | -19.3312 | -4.1329 | 18.8496 | 13.5792 | 44.3794 | QC'd by "Microsource" | ||||||||||||||||||||||
| Inhibitor | 12.5893 | 81.1747 | 42 | Partial curve; high efficacy | -4.9 | 4.095 | 0.9407 | -88.2352 | -7.0605 | -2.1 | 0 0 0 0 0 | -88.059 | -2.1141 | 2.5457 | -21.0606 | -24.383 | -88.059 | QC'd by "Microsource" | ||||||||||||||||||||||
| Inactive | 0 | 0.8 | 0.9754 | 0.5 | 18 | 4 | 0 0 0 0 0 | 0.1686 | 15.5939 | 9.5523 | 5.2389 | 3.3969 | 0.1686 | QC'd by "Microsource" | ||||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.516 | 14 | -11.1922 | 4 | 0 0 0 0 0 | 8.9233 | 2.0681 | -9.5798 | -21.4101 | -15.067 | 8.9233 | QC'd by "Microsource" | ||||||||||||||||||||||||||
| Inhibitor | 10 | 111.4578 | 10 | Partial curve; high efficacy; poor fit | -5 | 4.095 | 0.8557 | -88.0204 | 23.4373 | -2.3 | 0 0 0 0 0 | -86.963 | 0.1371 | 16.1149 | 55.0816 | -24.8092 | -86.963 | QC'd by "Microsource" | ||||||||||||||||||||||
| Inhibitor | 12.5893 | 111.8609 | 10 | Single point of activity | -4.9 | 1.3987 | 0.9539 | -66.6934 | 45.1675 | -3 | 0 0 0 0 0 | -51.9056 | 34.8895 | 58.2591 | 32.624 | 3.3045 | -51.9056 | QC'd by "Microsource" | ||||||||||||||||||||||
| Inactive | 0 | 4 | 9.4501 | 23.4721 | 50.1914 | -0.8776 | 27.4967 | 9.4501 | QC'd by "Microsource" | |||||||||||||||||||||||||||||||
| Inactive | 0 | 3.6272 | 0.9908 | -9.6077 | 22.5 | 4 | 0 0 0 0 0 | -9.2564 | 21.9907 | 20.6042 | 24.2232 | 8.6092 | -9.2564 | QC'd by "Microsource" | ||||||||||||||||||||||||||
| Activator | 0 | Single point of activity | 4.9549 | 0.3547 | 25.2512 | 5 | 3 | 0 0 0 0 1 | 15.4142 | 5.7176 | 6.5342 | 43.2316 | 7.0919 | 15.4142 | QC'd by "Microsource" | |||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.6074 | 7 | 18.5 | 4 | 0 0 0 0 0 | 11.6515 | 12.5897 | 21.5938 | 21.2209 | 4.3118 | 11.6515 | QC'd by "Microsource" | ||||||||||||||||||||||||||
| Activator | 2.2387 | 52.7895 | 0 | Partial curve; partial efficacy | -5.65 | 2.2526 | 0.9613 | 44.2358 | -8.5537 | 2.2 | 0 0 0 0 1 | -9.4264 | -2.4981 | -13.182 | 11.9591 | 42.1127 | -9.4264 | QC'd by "Microsource" | ||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.942 | 28 | 1.1909 | 4 | 0 0 0 0 1 | 1.5316 | 4.6729 | 1.2372 | -2.341 | 24.4478 | 1.5316 | QC'd by "Microsource" | ||||||||||||||||||||||||||
| Inhibitor | 35.4813 | 55.7622 | 10 | Single point of activity | -4.45 | 4.9549 | 0.7876 | -42.7915 | 12.9707 | -3 | 0 0 0 0 0 | -30.6839 | 14.5151 | 3.8713 | 4.7738 | 29.0235 | -30.6839 | QC'd by "Microsource" | ||||||||||||||||||||||
| Inhibitor | 35.4813 | 49.2317 | 10 | Single point of activity | -4.45 | 4.4495 | 0.7066 | -51.9324 | -2.7008 | -3 | 0 0 0 0 0 | -40.193 | -17.9891 | 11.8148 | -5.5992 | 0.7455 | -40.193 | QC'd by "Microsource" |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0000000311 uM | Activity at 0.0000000880 uM | Activity at 0.0000001756 uM | Activity at 0.0000004972 uM | Activity at 0.0000014063 uM | Activity at 0.0000028127 uM | Activity at 0.0000079555 uM | Activity at 0.0000225014 uM | Activity at 0.0000450029 uM | Activity at 0.0001299230 uM | Activity at 0.0003002708 uM | Activity at 0.0008965874 uM | Activity at 0.00268 uM | Activity at 0.00700 uM | Activity at 0.016 uM | Activity at 0.032 uM | Activity at 0.076 uM | Activity at 0.219 uM | Activity at 0.631 uM | Activity at 1.728 uM | Activity at 3.886 uM | Activity at 8.587 uM | Activity at 17.80 uM | Activity at 49.20 uM | Activity at 107.3 uM | Activity at 231.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inhibitor | 25.1189 | 46.3945 | 20 | Partial curve; partial efficacy | -4.6 | 2.2526 | 0.9287 | -51.2557 | -4.8612 | -2.2 | 0 0 0 0 0 | -41.1028 | -5.7868 | -8.9838 | -1.9677 | -26.4188 | -41.1028 | QC'd by "BIOMOL" | ||||||||||||||||||||||
| Inactive | 0 | 3.5117 | 0.9435 | 10 | -4.567 | 4 | 0 0 0 0 1 | -5.6299 | -3.6518 | -3.5753 | -4.2225 | 6.795 | -5.6299 | QC'd by "Prestwick Chemical; Inc." | ||||||||||||||||||||||||||
| Inactive | 0 | 3.0654 | 0.9376 | 11 | -2.7695 | 4 | 0 0 0 0 1 | -2.8045 | -1.4193 | -3.1412 | -1.9048 | 7.584 | -2.8045 | QC'd by "Prestwick Chemical; Inc." | ||||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.7625 | 1 | -16.7 | 4 | 0 0 0 0 | -0.288 | -12.25 | 5.019 | -2.495 | -0.288 | QC'd by "Prestwick Chemical; Inc." | |||||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.8335 | 4.5 | -7.0946 | 4 | 0 0 0 0 | 3.0138 | -4.2455 | 6.6652 | 3.4342 | 3.0138 | QC'd by "Prestwick Chemical; Inc." | |||||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.993 | 0.5 | -16.2895 | 4 | 0 0 0 0 1 | -17.2531 | -11.9079 | 0.4577 | 0.7459 | 0.1472 | -17.2531 | QC'd by "Prestwick Chemical; Inc." | ||||||||||||||||||||||||||
| Inactive | 0 | 3.0654 | 0.989 | -13.9862 | -8.1964 | 4 | 0 0 0 0 | -13.7385 | -8.6044 | -8.0804 | -9.4725 | -13.7385 | QC'd by "Prestwick Chemical; Inc." | |||||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.8435 | -11.2843 | 4 | 4 | 0 0 0 0 0 | -11.9036 | 3.4878 | 5.2393 | 0.5291 | 5.9839 | -11.9036 | QC'd by "Prestwick Chemical; Inc." | ||||||||||||||||||||||||||
| Inactive | 0 | 0.8 | 0.7241 | 0.6 | -14.6999 | 4 | 0 0 0 0 1 | -12.1307 | -11.4165 | -6.1179 | -8.0206 | -2.8333 | -12.1307 | QC'd by "Prestwick Chemical; Inc." | ||||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.8652 | 1 | -19.7041 | 4 | 0 0 0 0 0 | -4.2947 | -18.0867 | -15.9371 | 4.8395 | 2.1157 | -4.2947 | QC'd by "Prestwick Chemical; Inc." | ||||||||||||||||||||||||||
| Inhibitor | 14.1254 | 42.1465 | 10 | Single point of activity | -4.85 | 4.9549 | 0.8997 | -40.1465 | 2 | -3 | 0 0 0 0 0 | -41.8192 | -2.393 | 5.1804 | -2.5248 | 4.6867 | -41.8192 | QC'd by "Prestwick Chemical; Inc." | ||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.6566 | -10.2454 | 0 | 4 | 0 0 0 0 0 | -10.2045 | -4.5492 | -0.0989 | 4.6103 | -5.6017 | -10.2045 | QC'd by "Prestwick Chemical; Inc." | ||||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.5279 | 3 | -11.3522 | 4 | 0 0 0 0 | 1.078 | -15.7102 | -2.9932 | -14.9547 | 1.078 | QC'd by "Prestwick Chemical; Inc." | |||||||||||||||||||||||||||
| Inactive | 0 | 1.6924 | 0.9123 | 0.5 | -10.147 | 4 | 0 0 0 0 | 0.4297 | -9.2892 | -3.9336 | -3.1566 | 0.4297 | QC'd by "Prestwick Chemical; Inc." | |||||||||||||||||||||||||||
| Inactive | 0 | 2.4064 | 0.7886 | 8 | -4.3029 | 4 | 0 0 0 0 0 | 5.7256 | -1.9822 | -4.4191 | -3.8175 | 8.0142 | 5.7256 | QC'd by "Prestwick Chemical; Inc." | ||||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.997 | 5.5 | -12.076 | 4 | 0 0 0 1 | -6.5693 | -12.5633 | -7.4947 | 4.9219 | -6.5693 | QC'd by "Prestwick Chemical; Inc." | |||||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.9232 | -18.4489 | -2.2837 | 4 | 0 0 0 0 | -16.2075 | -1.3456 | -4.9534 | -0.2364 | -16.2075 | QC'd by "Prestwick Chemical; Inc." | |||||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.9481 | 2 | -17.5643 | 4 | 0 0 0 0 1 | -13.5121 | -12.9703 | 3.6247 | 1.4507 | 0.7522 | -13.5121 | QC'd by "Prestwick Chemical; Inc." | ||||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.5725 | -10.2193 | 7.5 | 4 | 0 0 0 0 0 | -12.7555 | 5.891 | 7.5423 | -18.5161 | 0.6587 | -12.7555 | QC'd by "Prestwick Chemical; Inc." | ||||||||||||||||||||||||||
| Inhibitor | 31.6228 | 100.7069 | 40 | Partial curve; high efficacy | -4.5 | 3.5722 | 0.9933 | -104.0783 | -3.3715 | -2.1 | 0 0 0 0 0 | -83.3961 | 0.3188 | -7.6251 | -4.9588 | -20.5702 | -83.3961 | QC'd by "BIOMOL" |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0001330000 uM | Activity at 0.0006670000 uM | Activity at 0.00133 uM | Activity at 0.00292 uM | Activity at 0.00509 uM | Activity at 0.00701 uM | Activity at 0.013 uM | Activity at 0.025 uM | Activity at 0.035 uM | Activity at 0.067 uM | Activity at 0.144 uM | Activity at 0.215 uM | Activity at 0.334 uM | Activity at 0.740 uM | Activity at 1.196 uM | Activity at 1.674 uM | Activity at 3.714 uM | Activity at 5.712 uM | Activity at 8.350 uM | Activity at 18.23 uM | Activity at 29.23 uM | Activity at 41.77 uM | Activity at 83.30 uM | Activity at 125.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cytotoxic | 1.9953 | 113.031 | 87 | Complete curve; high efficacy | -5.7 | 1.8851 | 0.9981 | -110.031 | 3 | -1.1 | 0 0 0 0 0 0 | -107.2427 | 2.2689 | 1.0042 | 0.9209 | -42.0576 | -106.1252 | -107.2427 | QC'd by SigmaAldrich | |||||||||||||||||||
| Cytotoxic | 1.7783 | 125.1696 | 87 | Complete curve; high efficacy | -5.75 | 0.9 | 0.9929 | -113.1696 | 12 | -1.1 | 0 0 0 0 0 0 | -103.0689 | 13.2856 | 5.2462 | -14.1694 | -43.8322 | -94.0024 | -103.0689 | QC'd by MedChem Express | |||||||||||||||||||
| Cytotoxic | 2.8184 | 94.2796 | 85 | Complete curve; high efficacy | -5.55 | 2.7868 | 0.9899 | -94.2796 | 0 | -1.1 | 0 0 0 0 0 0 | -92.9779 | -7.4665 | 6.8679 | 0.5084 | -17.9552 | -91.153 | -92.9779 | QC'd by ActiveBioChem | |||||||||||||||||||
| Cytotoxic | 3.9811 | 104.7007 | 85 | Complete curve; high efficacy | -5.4 | 1.9282 | 0.9876 | -108.7007 | -4 | -1.1 | 0 0 0 0 0 0 | -107.1999 | -9.8111 | 5.3105 | -9.0013 | -19.8039 | -88.8531 | -107.1999 | QC'd by Cayman | |||||||||||||||||||
| Cytotoxic | 3.9811 | 104.8133 | 84 | Complete curve; high efficacy | -5.4 | 4.9549 | 0.9975 | -97.8133 | 7 | -1.1 | 0 0 0 0 0 0 | -96.4628 | 2.9746 | 5.5778 | 9.9604 | 7.9067 | -96.3048 | -96.4628 | QC'd by Chemdiv | |||||||||||||||||||
| Cytotoxic | 7.9433 | 93.6312 | 43 | Partial curve; high efficacy | -5.1 | 1.8265 | 0.988 | -88.1312 | 5.5 | -2.1 | 0 0 0 0 0 0 | -81.16 | 7.4036 | -1.971 | 8.1518 | 2.5441 | -43.3262 | -81.16 | QC'd by Tocris | |||||||||||||||||||
| Cytotoxic | 11.2202 | 110.4684 | 43 | Partial curve; high efficacy | -4.95 | 4.095 | 0.985 | -119.5007 | -9.0324 | -2.1 | 0 0 0 0 0 0 | -118.5523 | -10.5119 | -11.9311 | -4.1937 | -19.0163 | -36.8591 | -118.5523 | QC'd by Selleck | |||||||||||||||||||
| Cytotoxic | 3.5481 | 83.9179 | 43 | Partial curve; partial efficacy | -5.45 | 0.9 | 0.9948 | -69.9179 | 14 | -2.2 | 0 0 0 0 0 0 | -61.5982 | 16.5841 | 8.808 | 3.9336 | -11.9394 | -44.1024 | -61.5982 | QC'd by MedChem Express | |||||||||||||||||||
| Cytotoxic | 10 | 74.6328 | 42 | Partial curve; partial efficacy | -5 | 4.5045 | 0.9705 | -73.1328 | 1.5 | -2.2 | 0 0 0 0 0 0 | -72.9235 | 4.7089 | -8.3955 | 2.447 | 6.6563 | -21.5584 | -72.9235 | QC'd by Microsource | |||||||||||||||||||
| Cytotoxic | 10 | 85.2865 | 42 | Partial curve; partial efficacy | -5 | 2.8473 | 0.9813 | -78.2865 | 7 | -2.2 | 0 0 0 0 0 0 | -76.1447 | 2.8336 | 4.2096 | 6.7575 | 15.5975 | -26.1115 | -76.1447 | QC'd by Selleck | |||||||||||||||||||
| Cytotoxic | 15.8489 | 110.283 | 42 | Partial curve; high efficacy | -4.8 | 4.095 | 0.9651 | -114.283 | -4 | -2.1 | 0 0 0 0 0 0 | -105.2329 | 4.5123 | -6.2646 | -15.7924 | -8.0922 | -13.0841 | -105.2329 | QC'd by APExBIO | |||||||||||||||||||
| Cytotoxic | 5.6234 | 59.1928 | 42 | Partial curve; partial efficacy | -5.25 | 1.7137 | 0.9927 | -64.1388 | -4.946 | -2.2 | 0 0 0 0 0 0 | -62.1656 | -1.205 | -6.6585 | -7.6087 | -10.5211 | -44.0933 | -62.1656 | QC'd by APExBIO | |||||||||||||||||||
| Cytotoxic | 11.2202 | 95.8421 | 42 | Partial curve; high efficacy | -4.95 | 4.9549 | 0.9946 | -108.9826 | -13.1404 | -2.1 | 0 0 0 0 0 0 | -108.765 | -13.9778 | -8.867 | -17.3979 | -12.3204 | -29.6896 | -108.765 | QC'd by Microsource | |||||||||||||||||||
| Cytotoxic | 14.1254 | 103.8132 | 42 | Partial curve; high efficacy | -4.85 | 4.095 | 0.9922 | -89.3132 | 14.5 | -2.1 | 0 0 0 0 0 0 | -82.8741 | 14.0675 | 11.603 | 18.4826 | 16.3404 | 1.5094 | -82.8741 | QC'd by Selleck | |||||||||||||||||||
| Cytotoxic | 15.8489 | 95.5525 | 41 | Partial curve; high efficacy | -4.8 | 4.095 | 0.9613 | -99.5525 | -4 | -2.1 | 0 0 0 0 0 0 | -92.1783 | -3.4956 | 1.341 | -1.2347 | -17.1643 | -12.6357 | -92.1783 | QC'd by Microsource | |||||||||||||||||||
| Cytotoxic | 22.3872 | 125.7512 | 41 | Partial curve; high efficacy | -4.65 | 4.095 | 0.9732 | -131.3763 | -5.6252 | -2.1 | 0 0 0 0 0 0 | -121.6448 | -4.6357 | -15.9 | -1.3543 | -17.0265 | -12.9576 | -121.6448 | QC'd by MedChem Express | |||||||||||||||||||
| Cytotoxic | 0.1122 | 45.0651 | 25 | Complete curve; partial efficacy | -6.95 | 1.4781 | 0.9909 | -39.5651 | 5.5 | -1.2 | 0 0 0 0 0 0 | -40.801 | 3.5169 | -8.4238 | -32.7672 | -35.2484 | -40.7085 | -40.801 | QC'd by BIOMOL | |||||||||||||||||||
| Cytotoxic | 1.4125 | 44.1947 | 23 | Complete curve; partial efficacy | -5.85 | 0.6 | 0.9492 | -43.8679 | 0.3268 | -1.2 | 0 0 0 0 0 0 | -41.0814 | -5.9543 | -3.061 | -21.5724 | -25.4792 | -35.5859 | -41.0814 | QC'd by SIGMA | |||||||||||||||||||
| Cytotoxic | 1 | 35.9562 | 23 | Complete curve; partial efficacy | -6 | 4.9549 | 0.9699 | -36.4562 | -0.5 | -1.2 | 0 0 0 0 0 0 | -36.8037 | -6.5836 | 1.7223 | 3.0776 | -34.6493 | -35.6313 | -36.8037 | QC'd by APExBIO | |||||||||||||||||||
| Cytotoxic | 1.9953 | 35.3993 | 22 | Complete curve; partial efficacy | -5.7 | 2.7202 | 0.9471 | -34.8993 | 0.5 | -1.2 | 0 0 0 0 0 0 | -28.9048 | -0.4564 | 2.4701 | -0.7641 | -13.0566 | -40.5876 | -28.9048 | QC'd by SigmaAldrich |
| Phenotype | Potency | Efficacy | Analysis Comment | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0003270000 uM | Activity at 0.0007732774 uM | Activity at 0.00163 uM | Activity at 0.00369 uM | Activity at 0.00818 uM | Activity at 0.020 uM | Activity at 0.030 uM | Activity at 0.047 uM | Activity at 0.101 uM | Activity at 0.151 uM | Activity at 0.243 uM | Activity at 0.477 uM | Activity at 0.759 uM | Activity at 1.287 uM | Activity at 2.393 uM | Activity at 3.818 uM | Activity at 6.336 uM | Activity at 11.99 uM | Activity at 19.37 uM | Activity at 31.37 uM | Activity at 60.11 uM | Activity at 107.2 uM | Activity at 158.4 uM | Activity at 229.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inactive | 4 | 0 0 0 0 0 | 1.4694 | -3.5669 | -6.235 | 2.8586 | 1.8042 | 1.4694 | QC'd by "Chem Div" | ||||||||||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 0 | -4.2631 | 8.2218 | 8.0811 | 10.2927 | -3.9947 | -4.2631 | QC'd by "Chem Div" | ||||||||||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 0 | 6.0369 | 0.3398 | -2.1048 | -8.1695 | -3.6822 | 6.0369 | QC'd by "Chem Div" | ||||||||||||||||||||||||||||
| Inactive | 4 | -2.0565 | 1.7294 | -3.5894 | -1.2575 | -0.5402 | -2.0565 | QC'd by "Chem Div" | |||||||||||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 1 | 2.3149 | 1.0048 | 4.6369 | -1.9963 | -3.3543 | 2.3149 | QC'd by "Chem Div" | ||||||||||||||||||||||||||||
| Inactive | 4 | 7.2748 | 7.1515 | 6.1372 | 1.5197 | 5.2332 | 7.2748 | QC'd by "Chem Div" | |||||||||||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 0 | 1.006 | -3.3873 | -7.786 | -9.3037 | -9.1761 | 1.006 | QC'd by "Chem Div" | ||||||||||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 0 | -0.0368 | -9.4458 | -10.5155 | -9.0065 | -12.9141 | -0.0368 | QC'd by "Chem Div" | ||||||||||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 0 | 2.6 | -7.8084 | -12.3007 | -2.0954 | -6.6887 | 2.6 | QC'd by "Chem Div" | ||||||||||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 0 | -11.4867 | -18.9051 | -17.4955 | -19.0735 | -9.6682 | -11.4867 | QC'd by "Chem Div" | ||||||||||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 0 | -7.5605 | -17.2173 | -11.0038 | -16.5656 | -22.4025 | -7.5605 | QC'd by "Chem Div" | ||||||||||||||||||||||||||||
| Inactive | 4 | -7.5451 | -1.1939 | -1.3084 | -5.8268 | -5.3206 | -7.5451 | QC'd by "Chem Div" | |||||||||||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 1 | -5.5852 | -4.3753 | -1.0046 | -3.1641 | -10.1524 | -5.5852 | QC'd by "Chem Div" | ||||||||||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 0 | 1.1172 | -6.0391 | 7.0118 | 9.0446 | 1.6533 | 1.1172 | QC'd by "Chem Div" | ||||||||||||||||||||||||||||
| Inactive | 4 | 2.3359 | 1.2518 | 1.6626 | -0.9325 | -0.9194 | 2.3359 | QC'd by "Chem Div" | |||||||||||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 | -19.5354 | 0.3984 | -4.1147 | 2.1883 | -19.5354 | QC'd by "Chem Div" | |||||||||||||||||||||||||||||
| Inactive | 4 | -5.6552 | -4.6769 | -1.9378 | -0.5867 | -3.224 | -5.6552 | QC'd by "Chem Div" | |||||||||||||||||||||||||||||
| Inactive | 4 | -11.3738 | -10.4148 | -13.8912 | -10.4252 | -7.8961 | -11.3738 | QC'd by "Chem Div" | |||||||||||||||||||||||||||||
| Inactive | 4 | -6.1571 | -8.7102 | -2.9113 | -5.2229 | -3.4369 | -6.1571 | QC'd by "Chem Div" | |||||||||||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 1 | -7.3803 | -8.8177 | -11.1654 | -6.5301 | -15.9483 | -7.3803 | QC'd by "Chem Div" |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0000062633 uM | Activity at 0.0000234000 uM | Activity at 0.0000299492 uM | Activity at 0.0000680174 uM | Activity at 0.0001469594 uM | Activity at 0.0003236290 uM | Activity at 0.0006759500 uM | Activity at 0.00129 uM | Activity at 0.00271 uM | Activity at 0.00485 uM | Activity at 0.00758 uM | Activity at 0.016 uM | Activity at 0.038 uM | Activity at 0.071 uM | Activity at 0.177 uM | Activity at 0.355 uM | Activity at 0.588 uM | Activity at 1.399 uM | Activity at 1.898 uM | Activity at 4.965 uM | Activity at 9.229 uM | Activity at 17.27 uM | Activity at 44.90 uM | Activity at 91.89 uM | Activity at 155.1 uM | Activity at 231.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inactive | 0 | 0 | 0 | 4 | 9.3597 | 0 | 0 | 0 | 0 | 0 | 2.2289 | 0 | 9.3597 | QC'd by Microsource | ||||||||||||||||||||||||||
| Inactive | 0 | -4.475 | 4.9549 | 0.8748 | -21.4867 | 4 | 4 | 0 0 0 0 0 0 0 0 | -17.0722 | 6.1042 | 2.8293 | 0 | 7.4025 | 0 | 6.1286 | 5.2151 | -17.0722 | QC'd by Vitas | ||||||||||||||||||||||
| Inactive | 0 | -8.275 | 1.1705 | 0.6611 | 2 | -6.667 | 4 | 0 0 0 0 0 0 0 0 | -1.0776 | -6.3892 | -2.9698 | -1.7372 | 5.874 | 0.3532 | 2.419 | 2.3477 | -1.0776 | QC'd by Labotest | ||||||||||||||||||||||
| Inactive | 0 | -4.425 | 4.9549 | 0.4933 | -23.5282 | -3 | 4 | 0 0 0 0 0 0 0 0 | -17.9402 | 0.3948 | -8.1012 | -10.4184 | -5.5544 | 1.8102 | -4.7765 | 5.7051 | -17.9402 | QC'd by Vitas | ||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 0 | 7.8331 | 0 | 0 | 9.3496 | 0 | 8.3936 | 8.8574 | 0 | QC'd by Sequoia | ||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 0 | 2.1346 | 2.0873 | 2.8787 | 2.1981 | 0 | 1.0717 | 0 | 0 | QC'd by SIGMA | ||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 0 | 6.7477 | 0 | 7.719 | 6.3706 | 0 | 0 | 0 | 0 | QC'd by Prestwick | ||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 1.3259 | 8.1273 | 0 | 0 | 7.3085 | 6.1485 | 9.7634 | 0 | 1.3259 | QC'd by Enzo | ||||||||||||||||||||||||||
| Inactive | 0 | -6.775 | 4.9549 | 0.7871 | -25.4234 | -14.7892 | 4 | 1 0 0 0 0 0 0 1 | -14.8266 | -40.4001 | -18.8558 | -14.3881 | -11.9076 | -28.2695 | -23.675 | -23.6904 | -14.8266 | QC'd by Microsource | ||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 0 | 0 | 0 | 3.2238 | 5.3823 | 0 | 7.5034 | 0 | 0 | QC'd by Microsource | ||||||||||||||||||||||||||
| Inactive | 0 | -4.475 | 4.9549 | 0.4377 | -10.0741 | 2 | 4 | 0 0 0 0 0 0 0 0 | -7.9784 | 0 | 0 | 6.8904 | -2.1283 | 0 | 0.7614 | 9.8865 | -7.9784 | QC'd by Labotest | ||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -2.1184 | 4.7394 | 4.4107 | -0.6138 | 5.1674 | 0 | 2.3218 | -1.3941 | -2.1184 | QC'd by Microsource | ||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 0 | 0.2342 | 2.9725 | 5.1318 | 0 | 2.0235 | 0 | 0.0589 | 0 | QC'd by Enzo | ||||||||||||||||||||||||||
| Inactive | 0 | -8.725 | 0.6 | 0.7945 | 4.5 | -11.9886 | 4 | 0 0 0 0 0 0 0 1 | -9.0185 | -8.3238 | -0.4567 | 0.9031 | 0.0721 | 3.3394 | 7.7262 | 3.0826 | -9.0185 | QC'd by Vitas | ||||||||||||||||||||||
| Inactive | 0 | -9.125 | 4.9549 | 0.5569 | 5 | -5.3552 | 4 | 0 0 0 0 0 0 0 1 | -2.6103 | -2.796 | 6.9995 | 3.4228 | 1.6101 | 8.0983 | 7.0134 | 2.0138 | -2.6103 | QC'd by Specs | ||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 0.9896 | 0 | 0 | 9.6344 | 0 | 0 | 4.2786 | 0 | 0.9896 | QC'd by GVK | ||||||||||||||||||||||||||
| Inactive | 0 | -5.525 | 4.095 | 0.6337 | -3.6963 | 3 | 4 | 0 0 0 0 0 0 0 0 | -3.4671 | 3.2926 | 6.7211 | 0 | 4.9171 | 0 | 2.2046 | -3.4969 | -3.4671 | QC'd by Prestwick | ||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 3.1269 | 3.0732 | 0 | 6.5383 | 2.8274 | 0 | -3.4128 | 8.3114 | 3.1269 | QC'd by Labotest | ||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 0 | 0 | 2.578 | 6.6592 | 0 | 0 | 0 | 3.3663 | 0 | QC'd by Prestwick | ||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 2.6761 | 0 | 0 | 8.9375 | 0 | 0 | 0.408 | 0 | 2.6761 | QC'd by Prestwick Chemical; Inc. |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0000062633 uM | Activity at 0.0000234000 uM | Activity at 0.0000299492 uM | Activity at 0.0000680174 uM | Activity at 0.0001469594 uM | Activity at 0.0003236290 uM | Activity at 0.0006759500 uM | Activity at 0.00129 uM | Activity at 0.00271 uM | Activity at 0.00485 uM | Activity at 0.00758 uM | Activity at 0.016 uM | Activity at 0.038 uM | Activity at 0.071 uM | Activity at 0.177 uM | Activity at 0.355 uM | Activity at 0.588 uM | Activity at 1.399 uM | Activity at 1.898 uM | Activity at 4.965 uM | Activity at 9.229 uM | Activity at 17.27 uM | Activity at 44.90 uM | Activity at 91.89 uM | Activity at 155.1 uM | Activity at 231.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inhibitor | 0.0015 | 95.0131 | 100 | Complete curve; high efficacy | -8.8295 | 4.9549 | 0.995 | -92.9859 | 2.0272 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -96.2587 | -1.6791 | -84.9271 | -90.9202 | -90.8631 | -90.7375 | -92.2911 | -92.6732 | -94.1019 | -94.0673 | -96.0913 | -96.2587 | QC'd by SIGMA | ||||||||||||||||
| Inhibitor | 0.0017 | 96.0144 | 100 | Complete curve; high efficacy | -8.7683 | 3.2475 | 0.9987 | -95.3786 | 0.6358 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -96.9294 | 1.7123 | -0.1391 | -34.4453 | -93.3159 | -93.9442 | -94.1795 | -94.3745 | -94.7424 | -94.9325 | -95.6129 | -96.9294 | QC'd by MedChem Express | ||||||||||||||||
| Inhibitor | 0.0017 | 101.1335 | 100 | Complete curve; high efficacy | -8.7683 | 4.5045 | 0.9988 | -96.4557 | 4.6778 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -98.6254 | 2.9383 | 5.3252 | -23.8352 | -93.6078 | -94.3407 | -94.7755 | -96.5382 | -96.9802 | -98.093 | -97.488 | -98.6254 | QC'd by MedChem Express | ||||||||||||||||
| Inhibitor | 0.0014 | 95.7664 | 100 | Complete curve; high efficacy | -8.8683 | 3.0654 | 0.9932 | -91.7312 | 4.0352 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -94.3736 | 0 | 6.5073 | -50.3576 | -85.2142 | -89.4583 | -90.3553 | -90.6328 | -93.2878 | -91.6178 | -92.6738 | -94.3736 | QC'd by MedChem Express | ||||||||||||||||
| Inhibitor | 0.0027 | 92.0567 | 99 | Complete curve; high efficacy | -8.575 | 3.99 | 0.9971 | -93.082 | -1.0254 | -1.1 | 0 0 0 0 0 0 0 0 | -97.5703 | -1.153 | -56.5542 | -91.9507 | -92.331 | -93.0234 | -92.9105 | -92.2466 | -97.5703 | QC'd by Alfa Aesar | |||||||||||||||||||
| Inhibitor | 0.0027 | 86.1528 | 99 | Complete curve; high efficacy | -8.575 | 4.9549 | 0.9984 | -92.0573 | -5.9045 | -1.1 | 0 0 0 0 0 0 0 0 | -92.9872 | -5.0961 | -62.3948 | -91.5014 | -91.2009 | -92.0539 | -90.8793 | -91.9519 | -92.9872 | QC'd by Microsource | |||||||||||||||||||
| Inhibitor | 0.0021 | 98.4878 | 99 | Complete curve; high efficacy | -8.675 | 4.5045 | 0.9983 | -91.9795 | 6.5083 | -1.1 | 0 0 0 0 0 0 0 0 | -94.0485 | 5.8681 | -73.3835 | -89.9758 | -90.798 | -91.9458 | -91.2065 | -93.7497 | -94.0485 | QC'd by Bosche | |||||||||||||||||||
| Inhibitor | 7.0E-4 | 82.7334 | 99 | Complete curve; high efficacy | -9.175 | 0.6 | 0.8847 | -82.6567 | 0.0767 | -1.1 | 0 0 0 0 0 0 0 0 | -94.3569 | -37.5208 | -62.7186 | -72.7916 | -74.3825 | -79.8918 | -76.6331 | -78.5528 | -94.3569 | QC'd by Selleck | |||||||||||||||||||
| Inhibitor | 0.0037 | 95.0819 | 99 | Complete curve; high efficacy | -8.4362 | 1.2221 | 0.9994 | -94.5205 | 0.5614 | -1.1 | 0 0 0 0 0 0 0 | -93.7704 | -1.1631 | 0.6157 | -11.9264 | -47.6173 | -82.383 | -92.7843 | -93.7704 | QC'd by Adooq | ||||||||||||||||||||
| Inhibitor | 0.0033 | 94.0479 | 99 | Complete curve; high efficacy | -8.4795 | 3.5117 | 0.9958 | -93.9623 | 0.0856 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -97.8774 | 1.2665 | -23.1756 | -88.8678 | -90.2585 | -91.8229 | -92.3997 | -94.1271 | -95.2991 | -93.6757 | -95.8566 | -97.8774 | QC'd by MedChem Express | ||||||||||||||||
| Inhibitor | 0.0047 | 102.0075 | 98 | Complete curve; high efficacy | -8.3295 | 2.2481 | 0.997 | -94.1763 | 7.8312 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -98.7173 | 5.6987 | -9.7434 | -65.3554 | -90.638 | -91.2058 | -92.371 | -92.7427 | -94.2549 | -94.3053 | -96.979 | -98.7173 | QC'd by GVK | ||||||||||||||||
| Inhibitor | 0.0047 | 100.429 | 98 | Complete curve; high efficacy | -8.325 | 3.6772 | 0.9994 | -93.2276 | 7.2013 | -1.1 | 0 0 0 0 0 0 0 0 | -94.7435 | 8.1328 | -8.6557 | -90.5176 | -92.1158 | -93.5383 | -93.4255 | -92.4974 | -94.7435 | QC'd by Prestwick | |||||||||||||||||||
| Inhibitor | 0.0038 | 96.7634 | 98 | Complete curve; high efficacy | -8.425 | 3.99 | 0.9994 | -92.0205 | 4.743 | -1.1 | 0 0 0 0 0 0 0 0 | -93.5167 | 4.0536 | -21.1619 | -91.8053 | -91.1174 | -91.9789 | -90.7784 | -91.2901 | -93.5167 | QC'd by Selleck | |||||||||||||||||||
| Inhibitor | 0.0045 | 90.5397 | 98 | Complete curve; high efficacy | -8.3466 | 4.5045 | 0.9995 | -92.4565 | -1.9167 | -1.1 | 0 0 0 0 0 0 0 | -93.156 | -4.128 | -89.5728 | -91.2217 | -93.3904 | -92.524 | -93.0057 | -93.156 | QC'd by Selleck | ||||||||||||||||||||
| Inhibitor | 0.0052 | 98.2987 | 98 | Complete curve; high efficacy | -8.288 | 4.9549 | 0.9993 | -92.6581 | 5.6406 | -1.1 | 0 0 0 0 0 0 0 | -93.5941 | 0 | -91.9394 | -91.381 | -91.3804 | -93.5391 | -93.3571 | -93.5941 | QC'd by ChemieTek | ||||||||||||||||||||
| Inhibitor | 0.0052 | 98.8546 | 98 | Complete curve; high efficacy | -8.288 | 0.6 | 0.9861 | -94.1197 | 4.7349 | -1.1 | 0 0 0 0 0 0 0 | -93.9318 | -33.6729 | -64.3585 | -76.1096 | -84.2151 | -92.4038 | -93.1111 | -93.9318 | QC'd by MedChem Express | ||||||||||||||||||||
| Inhibitor | 0.004 | 86.0426 | 98 | Complete curve; high efficacy | -8.3992 | 4.5045 | 0.9996 | -92.288 | -6.2454 | -1.1 | 0 0 0 0 0 0 0 | -91.795 | -7.0299 | -86.4668 | -91.4418 | -93.2202 | -92.6549 | -92.4417 | -91.795 | QC'd by Selleck | ||||||||||||||||||||
| Inhibitor | 0.0046 | 98.0203 | 98 | Complete curve; high efficacy | -8.338 | 3.5117 | 0.9996 | -93.1684 | 4.8519 | -1.1 | 0 0 0 0 0 0 0 | -93.7644 | -11.8828 | -91.4502 | -92.2553 | -94.1095 | -92.9439 | -93.2642 | -93.7644 | QC'd by SIGMA | ||||||||||||||||||||
| Inhibitor | 0.0042 | 104.4497 | 98 | Complete curve; high efficacy | -8.3795 | 4.9549 | 0.9968 | -93.9204 | 10.5293 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -96.6259 | 8.6675 | 7.5142 | -90.2575 | -91.0844 | -91.1114 | -92.6871 | -93.2743 | -95.4523 | -94.079 | -95.5345 | -96.6259 | QC'd by BioAustralis | ||||||||||||||||
| Inhibitor | 0.0042 | 94.9421 | 98 | Complete curve; high efficacy | -8.3795 | 2.8473 | 0.9968 | -94.7591 | 0.183 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -96.9399 | 0.6808 | -16.1375 | -78.234 | -91.1234 | -91.9081 | -92.3507 | -95.4781 | -97.4887 | -95.7111 | -95.4747 | -96.9399 | QC'd by ActiveBioChem |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0000062652 uM | Activity at 0.0000234000 uM | Activity at 0.0000299754 uM | Activity at 0.0000680318 uM | Activity at 0.0001469781 uM | Activity at 0.0003237363 uM | Activity at 0.0006761082 uM | Activity at 0.00130 uM | Activity at 0.00271 uM | Activity at 0.00486 uM | Activity at 0.00759 uM | Activity at 0.016 uM | Activity at 0.038 uM | Activity at 0.071 uM | Activity at 0.177 uM | Activity at 0.356 uM | Activity at 0.588 uM | Activity at 1.402 uM | Activity at 1.903 uM | Activity at 4.972 uM | Activity at 9.253 uM | Activity at 17.29 uM | Activity at 44.98 uM | Activity at 91.90 uM | Activity at 155.1 uM | Activity at 231.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cytotoxic | 0.008 | 82.2034 | 84 | Complete curve; high efficacy | -8.0992 | 1.01 | 0.9669 | 21.0427 | 103.2462 | -1.1 | 0 0 0 0 0 0 0 | 13.1884 | 95.4748 | 59.0672 | 35.8423 | 31.6652 | 21.9238 | 22.0706 | 13.1884 | QC'd by Analyticon | ||||||||||||||||||||
| Cytotoxic | 0.0259 | 81.0572 | 83 | Complete curve; high efficacy | -7.5862 | 4.9549 | 0.923 | 16.4972 | 97.5544 | -1.1 | 0 0 0 0 0 0 0 | 2.5125 | 97.0035 | 93.2685 | 8.947 | 36.6707 | 23.4209 | 12.5374 | 2.5125 | QC'd by MedChem Express | ||||||||||||||||||||
| Cytotoxic | 0.8199 | 85.2901 | 83 | Complete curve; high efficacy | -6.0862 | 1.7529 | 0.994 | 32.3577 | 117.6478 | -1.1 | 0 0 0 0 0 0 0 | 34.7953 | 115.2038 | 115.6711 | 122.13 | 98.3734 | 49.1232 | 31.0106 | 34.7953 | QC'd by Glixx | ||||||||||||||||||||
| Cytotoxic | 0.01 | 90.4383 | 83 | Complete curve; high efficacy | -7.9992 | 1.0641 | 0.9856 | 19.9781 | 110.4164 | -1.1 | 0 0 0 0 0 0 0 | 13.8267 | 101.7041 | 71.2241 | 35.8056 | 28.6279 | 25.0828 | 19.4787 | 13.8267 | QC'd by Analyticon | ||||||||||||||||||||
| Cytotoxic | 0.0092 | 105.8361 | 83 | Complete curve; high efficacy | -8.0362 | 4.095 | 0.9984 | 16.204 | 122.0401 | -1.1 | 0 0 0 0 0 0 0 | 13.8473 | 120.9689 | 28.8486 | 18.131 | 17.3683 | 17.3537 | 14.6878 | 13.8473 | QC'd by SIGMA | ||||||||||||||||||||
| Cytotoxic | 0.4683 | 84.0955 | 83 | Complete curve; high efficacy | -6.3295 | 4.4495 | 0.969 | 29.5128 | 113.6083 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 21.2667 | 108.9911 | 100.6389 | 111.6185 | 114.5273 | 123.8697 | 121.8467 | 50.4844 | 36.163 | 35.4913 | 26.9501 | 21.2667 | QC'd by MedChem Express | ||||||||||||||||
| Cytotoxic | 0.1048 | 82.7642 | 82 | Complete curve; high efficacy | -6.9795 | 1.4163 | 0.9838 | 12.6322 | 95.3964 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 10.5755 | 88.3117 | 93.0926 | 98.2096 | 96.7434 | 61.0096 | 38.8636 | 20.851 | 15.783 | 15.7035 | 9.9048 | 10.5755 | QC'd by BIOMOL | ||||||||||||||||
| Cytotoxic | 0.1778 | 91.155 | 82 | Complete curve; high efficacy | -6.75 | 0.6 | 0.9671 | 13.9433 | 105.0983 | -1.1 | 0 0 0 0 0 0 0 | 9.949 | 96.7816 | 88.0056 | 52.4837 | 44.6307 | 29.7677 | 23.4253 | 9.949 | QC'd by Waterstone | ||||||||||||||||||||
| Cytotoxic | 0.0106 | 101.8256 | 82 | Complete curve; high efficacy | -7.975 | 2.7202 | 0.9927 | 11.1635 | 112.9891 | -1.1 | 0 0 0 0 0 0 0 0 | 10.2995 | 105.5432 | 116.5795 | 42.3861 | 10.2101 | 10.8286 | 11.4633 | 11.6468 | 10.2995 | QC'd by Prestwick | |||||||||||||||||||
| Cytotoxic | 0.6684 | 97.5838 | 82 | Complete curve; high efficacy | -6.175 | 2.3332 | 0.9902 | 18.8259 | 116.4097 | -1.1 | 0 0 0 0 0 0 0 0 | 15.8771 | 121.1891 | 108.6953 | 122.087 | 113.8515 | 96.8463 | 25.1626 | 23.9853 | 15.8771 | QC'd by Enzo | |||||||||||||||||||
| Cytotoxic | 0.0422 | 99.1812 | 82 | Complete curve; high efficacy | -7.375 | 1.3443 | 0.9933 | 10.554 | 109.7352 | -1.1 | 0 0 0 0 0 0 0 0 | 10.7613 | 114.3989 | 100.7838 | 90.7065 | 44.4742 | 11.2028 | 13.8457 | 11.3616 | 10.7613 | QC'd by Tocris | |||||||||||||||||||
| Cytotoxic | 0.0075 | 84.1066 | 82 | Complete curve; high efficacy | -8.125 | 4.9549 | 0.9983 | 9.4344 | 93.541 | -1.1 | 0 0 0 0 0 0 0 0 | 6.5354 | 91.7985 | 94.1104 | 12.6655 | 11.0929 | 8.6327 | 9.9971 | 10.0754 | 6.5354 | QC'd by Bosche | |||||||||||||||||||
| Cytotoxic | 0.4217 | 85.9203 | 82 | Complete curve; high efficacy | -6.375 | 0.8 | 0.9622 | 21.4982 | 107.4185 | -1.1 | 0 0 0 0 0 0 0 0 | 16.639 | 100.4185 | 107.3168 | 112.8293 | 84.5993 | 67.8817 | 38.3542 | 37.8797 | 16.639 | QC'd by Vitas | |||||||||||||||||||
| Cytotoxic | 0.1458 | 95.7444 | 82 | Complete curve; high efficacy | -6.8362 | 1.5579 | 0.9766 | 14.7016 | 110.446 | -1.1 | 0 0 0 0 0 0 0 | 4.7392 | 104.3625 | 115.3478 | 84.3787 | 31.7905 | 25.5998 | 18.0336 | 4.7392 | QC'd by Microsource | ||||||||||||||||||||
| Cytotoxic | 0.0036 | 107.2473 | 82 | Complete curve; high efficacy | -8.444 | 4.9549 | 0.9989 | 8.6172 | 115.8646 | -1.1 | 0 0 0 0 0 0 0 | 7.4398 | 110.6482 | 9.2236 | 10.0332 | 9.492 | 8.9141 | 6.3221 | 7.4398 | QC'd by Selleck | ||||||||||||||||||||
| Cytotoxic | 0.1636 | 80.2947 | 82 | Complete curve; high efficacy | -6.7862 | 2.0479 | 0.9763 | 17.795 | 98.0898 | -1.1 | 0 0 0 0 0 0 0 | 6.7352 | 100.4625 | 95.5674 | 85.028 | 29.2532 | 27.683 | 20.0892 | 6.7352 | QC'd by Selleck | ||||||||||||||||||||
| Cytotoxic | 0.0231 | 97.6406 | 82 | Complete curve; high efficacy | -7.6362 | 4.9549 | 0.9995 | 10.3864 | 108.027 | -1.1 | 0 0 0 0 0 0 0 | 10.177 | 107.941 | 98.6844 | 9.8351 | 11.6961 | 11.6717 | 8.8001 | 10.177 | QC'd by Selleck | ||||||||||||||||||||
| Cytotoxic | 1.5877 | 86.3274 | 82 | Complete curve; high efficacy | -5.7992 | 1.331 | 0.9642 | 23.21 | 109.5374 | -1.1 | 0 0 0 0 0 0 0 | 29.2744 | 118.4556 | 99.7114 | 104.7412 | 100.9923 | 85.0976 | 33.9221 | 29.2744 | QC'd by MedChem Express | ||||||||||||||||||||
| Cytotoxic | 0.0146 | 89.4885 | 82 | Complete curve; high efficacy | -7.8362 | 1.2876 | 0.9952 | 9.3441 | 98.8326 | -1.1 | 0 0 0 0 0 0 0 | 7.0005 | 90.7029 | 51.5567 | 22.536 | 11.8774 | 9.8565 | 8.188 | 7.0005 | QC'd by SynKinase | ||||||||||||||||||||
| Cytotoxic | 0.0065 | 96.8431 | 82 | Complete curve; high efficacy | -8.1862 | 4.095 | 0.9948 | 8.9496 | 105.7927 | -1.1 | 0 0 0 0 0 0 0 | 3.839 | 102.1209 | 12.4453 | 11.4448 | 10.8821 | 9.8966 | 7.7027 | 3.839 | QC'd by Selleck |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0000062652 uM | Activity at 0.0000234000 uM | Activity at 0.0000299754 uM | Activity at 0.0000680318 uM | Activity at 0.0001469781 uM | Activity at 0.0003237363 uM | Activity at 0.0006761082 uM | Activity at 0.00130 uM | Activity at 0.00271 uM | Activity at 0.00486 uM | Activity at 0.00759 uM | Activity at 0.016 uM | Activity at 0.038 uM | Activity at 0.071 uM | Activity at 0.177 uM | Activity at 0.356 uM | Activity at 0.588 uM | Activity at 1.402 uM | Activity at 1.903 uM | Activity at 4.972 uM | Activity at 9.253 uM | Activity at 17.29 uM | Activity at 44.98 uM | Activity at 91.90 uM | Activity at 155.1 uM | Activity at 231.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cytotoxic | 0.0166 | 89.5276 | 84 | Complete curve; high efficacy | -7.7795 | 2.0937 | 0.9442 | 25.8586 | 115.3863 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 5.6755 | 108.6505 | 117.9375 | 108.1166 | 52.7453 | 48.9938 | 23.9892 | 28.8508 | 25.6865 | 29.0357 | 27.3193 | 5.6755 | QC'd by MedChem Express | ||||||||||||||||
| Cytotoxic | 0.02 | 81.2231 | 83 | Complete curve; high efficacy | -7.6992 | 0.8 | 0.9723 | 16.8197 | 98.0429 | -1.1 | 0 0 0 0 0 0 0 | 8.455 | 90.2193 | 74.5452 | 44.2913 | 28.1409 | 27.059 | 21.5506 | 8.455 | QC'd by Analyticon | ||||||||||||||||||||
| Cytotoxic | 0.0326 | 86.5937 | 83 | Complete curve; high efficacy | -7.4862 | 0.7 | 0.953 | 18.8792 | 105.4729 | -1.1 | 0 0 0 0 0 0 0 | 8.4532 | 96.8084 | 73.0667 | 45.4397 | 34.5525 | 29.7666 | 27.4306 | 8.4532 | QC'd by MedChem Express | ||||||||||||||||||||
| Cytotoxic | 0.016 | 83.3126 | 82 | Complete curve; high efficacy | -7.7964 | 4.9549 | 0.9968 | 9.6075 | 92.9201 | -1.1 | 0 0 0 0 0 0 0 0 | 9.7773 | 89.2976 | 96.4187 | 11.9953 | 9.7167 | 8.8677 | 9.7542 | 10.3503 | 9.7773 | QC'd by LightBiologicals | |||||||||||||||||||
| Cytotoxic | 0.0106 | 94.2951 | 82 | Complete curve; high efficacy | -7.975 | 3.132 | 0.9955 | 11.6947 | 105.9898 | -1.1 | 0 0 0 0 0 0 0 0 | 11.6947 | 100.9198 | 109.3944 | 35.8242 | 11.7569 | 10.7934 | 12.3836 | 13.3145 | 11.6947 | QC'd by Prestwick | |||||||||||||||||||
| Cytotoxic | 0.0027 | 88.9753 | 82 | Complete curve; high efficacy | -8.575 | 4.9549 | 0.9992 | 8.9074 | 97.8826 | -1.1 | 0 0 0 0 0 0 0 0 | 6.9034 | 97.9914 | 42.2936 | 9.9686 | 9.1038 | 8.2217 | 9.3052 | 9.0933 | 6.9034 | QC'd by Alfa Aesar | |||||||||||||||||||
| Cytotoxic | 0.0084 | 80.5139 | 82 | Complete curve; high efficacy | -8.075 | 4.9549 | 0.9973 | 8.8938 | 89.4076 | -1.1 | 0 0 0 0 0 0 0 0 | 6.3577 | 87.1572 | 91.3499 | 12.9571 | 11.0421 | 10.3402 | 8.9116 | 9.8618 | 6.3577 | QC'd by Bosche | |||||||||||||||||||
| Cytotoxic | 0.0051 | 97.542 | 82 | Complete curve; high efficacy | -8.294 | 4.5045 | 0.9992 | 8.7153 | 106.2574 | -1.1 | 0 0 0 0 0 0 0 | 7.9842 | 105.0472 | 13.7629 | 9.4904 | 9.8464 | 7.6546 | 7.149 | 7.9842 | QC'd by Selleck | ||||||||||||||||||||
| Cytotoxic | 0.0206 | 94.4998 | 82 | Complete curve; high efficacy | -7.6862 | 4.095 | 0.9984 | 11.2634 | 105.7632 | -1.1 | 0 0 0 0 0 0 0 | 10.8677 | 105.3873 | 87.5417 | 14.4142 | 11.9765 | 9.1461 | 9.2097 | 10.8677 | QC'd by Selleck | ||||||||||||||||||||
| Cytotoxic | 0.4611 | 93.5292 | 82 | Complete curve; high efficacy | -6.3362 | 1.4641 | 0.9637 | 18.0367 | 111.5659 | -1.1 | 0 0 0 0 0 0 0 | 6.0375 | 113.1729 | 110.6758 | 104.0276 | 72.579 | 24.3332 | 35.3731 | 6.0375 | QC'd by ChemieTek | ||||||||||||||||||||
| Cytotoxic | 0.0259 | 83.4079 | 82 | Complete curve; high efficacy | -7.5862 | 1.1705 | 0.9942 | 10.3799 | 93.7878 | -1.1 | 0 0 0 0 0 0 0 | 5.5192 | 87.4844 | 66.3422 | 28.5401 | 16.4338 | 12.1449 | 11.8707 | 5.5192 | QC'd by MedChem Express | ||||||||||||||||||||
| Cytotoxic | 0.0206 | 80.2779 | 82 | Complete curve; high efficacy | -7.6862 | 3.6772 | 0.9705 | 14.5871 | 94.865 | -1.1 | 0 0 0 0 0 0 0 | 7.2915 | 96.262 | 74.9595 | 27.5419 | 14.6063 | 13.1849 | 10.6575 | 7.2915 | QC'd by MedChem Express | ||||||||||||||||||||
| Cytotoxic | 0.0259 | 99.9965 | 82 | Complete curve; high efficacy | -7.5862 | 1.1105 | 0.9627 | 10.993 | 110.9895 | -1.1 | 0 0 0 0 0 0 0 | 3.5224 | 101.8192 | 78.6727 | 30.3442 | 20.1042 | 25.1119 | 4.4796 | 3.5224 | QC'd by APExBIO | ||||||||||||||||||||
| Cytotoxic | 0.0146 | 90.7895 | 82 | Complete curve; high efficacy | -7.8362 | 1.3437 | 0.996 | 9.1094 | 99.8989 | -1.1 | 0 0 0 0 0 0 0 | 6.2123 | 91.4196 | 53.8318 | 19.2776 | 13.6662 | 8.5618 | 7.4372 | 6.2123 | QC'd by APExBIO | ||||||||||||||||||||
| Cytotoxic | 0.6513 | 81.7203 | 82 | Complete curve; high efficacy | -6.1862 | 1.4787 | 0.9896 | 21.402 | 103.1224 | -1.1 | 0 0 0 0 0 0 0 | 21.0506 | 108.9081 | 95.7413 | 101.2028 | 78.0357 | 34.6634 | 24.9893 | 21.0506 | QC'd by Glixx | ||||||||||||||||||||
| Cytotoxic | 0.013 | 84.0074 | 82 | Complete curve; high efficacy | -7.8862 | 1.4163 | 0.9944 | 10.0699 | 94.0773 | -1.1 | 0 0 0 0 0 0 0 | 5.9786 | 86.0882 | 47.3557 | 17.8996 | 13.5824 | 10.5199 | 10.422 | 5.9786 | QC'd by MedChem Express | ||||||||||||||||||||
| Cytotoxic | 0.082 | 85.0686 | 82 | Complete curve; high efficacy | -7.0862 | 0.91 | 0.9915 | 14.099 | 99.1676 | -1.1 | 0 0 0 0 0 0 0 | 10.2171 | 94.6065 | 84.9239 | 59.8081 | 27.5521 | 23.6905 | 16.7893 | 10.2171 | QC'd by Glixx | ||||||||||||||||||||
| Cytotoxic | 0.0065 | 84.6353 | 82 | Complete curve; high efficacy | -8.1862 | 4.095 | 0.9982 | 8.8501 | 93.4854 | -1.1 | 0 0 0 0 0 0 0 | 6.5017 | 90.3725 | 11.9975 | 10.2939 | 10.111 | 9.5279 | 8.2521 | 6.5017 | QC'd by APExBIO | ||||||||||||||||||||
| Cytotoxic | 0.009 | 82.7243 | 82 | Complete curve; high efficacy | -8.044 | 1.2876 | 0.9917 | 10.512 | 93.2363 | -1.1 | 0 0 0 0 0 0 0 | 7.7344 | 85.5143 | 46.4791 | 22.475 | 13.1909 | 9.7487 | 11.7333 | 7.7344 | QC'd by MedChem Express | ||||||||||||||||||||
| Cytotoxic | 4.0E-4 | 94.196 | 82 | Complete curve; high efficacy | -9.375 | 2.4064 | 0.9988 | 7.7324 | 101.9284 | -1.1 | 0 0 0 0 0 0 0 | 7.3587 | 100.7694 | 74.7197 | 9.8839 | 9.6058 | 8.6476 | 8.4903 | 7.3587 | QC'd by SIGMA |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0000420468 uM | Activity at 0.0001060182 uM | Activity at 0.0001893301 uM | Activity at 0.0004489405 uM | Activity at 0.0009664426 uM | Activity at 0.00171 uM | Activity at 0.00292 uM | Activity at 0.00536 uM | Activity at 0.00931 uM | Activity at 0.020 uM | Activity at 0.041 uM | Activity at 0.085 uM | Activity at 0.146 uM | Activity at 0.251 uM | Activity at 0.501 uM | Activity at 1.073 uM | Activity at 2.225 uM | Activity at 4.221 uM | Activity at 6.452 uM | Activity at 12.64 uM | Activity at 29.84 uM | Activity at 57.50 uM | Activity at 114.0 uM | Activity at 227.6 uM | Activity at 379.2 uM | Activity at 573.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inactive | 0 | 0 | 0 | 4 | -8.3336 | -1.4117 | -0.6141 | -1.8079 | 0.0446 | -8.3336 | QC'd by Sytravon | |||||||||||||||||||||||||||||
| Inactive | 0 | -5.75 | 4.9549 | 0.364 | -29.4824 | 3.3805 | 4 | 0 0 0 0 1 | -1.3954 | 3.2535 | 0.7839 | -59.1373 | 6.0E-4 | -1.3954 | QC'd by Sytravon | |||||||||||||||||||||||||
| Inactive | 0 | -6.75 | 3.132 | 0.7843 | 0.8702 | 12.5 | 4 | 0 0 0 0 0 | 4.4963 | 10.2975 | -0.4426 | -1.3582 | 0.1626 | 4.4963 | QC'd by Sytravon | |||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 2.0548 | -1.7066 | -2.8833 | -2.005 | 0.3693 | 2.0548 | QC'd by Sytravon | |||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -5.6422 | 0.4339 | -3.0268 | -4.4255 | -2.8516 | -5.6422 | QC'd by Sytravon | |||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 0.2315 | -0.9193 | -0.9625 | 13.7196 | -1.9704 | 0.2315 | QC'd by Sytravon | |||||||||||||||||||||||||||||
| Inactive | 0 | -5.05 | 4.9549 | 0.5023 | -0.0525 | 7.5 | 4 | 0 0 0 0 1 | 5.313 | 2.7111 | 12.7202 | 1.5451 | -0.0438 | 5.313 | QC'd by Sytravon | |||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 4.3883 | -3.3207 | -0.3808 | -0.1461 | -2.971 | 4.3883 | QC'd by Sytravon | |||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 5.7635 | -0.6995 | -1.7294 | 6.1024 | 1.8317 | 5.7635 | QC'd by Sytravon | |||||||||||||||||||||||||||||
| Inactive | 0 | -4.3 | 1.0693 | 0.8616 | -4.2573 | 9.5 | 4 | 0 0 0 0 0 | -1.8811 | 11.1484 | 8.5502 | 5.9885 | 4.608 | -1.8811 | QC'd by Sytravon | |||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -1.7273 | -3.4115 | -0.1881 | -2.6331 | -1.6916 | -1.7273 | QC'd by Sytravon | |||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 4.3895 | -3.0627 | -1.1001 | 4.7802 | 0.8642 | 4.3895 | QC'd by Sytravon | |||||||||||||||||||||||||||||
| Inactive | 0 | -5 | 4.9549 | 0.6649 | 10.5 | 0.7021 | 4 | 0 0 0 0 0 | 13.7837 | 4.4863 | -3.5816 | 7.2204 | 7.3678 | 13.7837 | QC'd by Sytravon | |||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 6.0179 | 3.343 | 6.8931 | 2.2936 | 4.5224 | 6.0179 | QC'd by Sytravon | |||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 11.3207 | 3.0878 | 5.164 | 2.5572 | 5.3615 | 11.3207 | QC'd by Sytravon | |||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 8.7383 | 3.2664 | 2.7307 | 3.2405 | 1.8463 | 8.7383 | QC'd by Sytravon | |||||||||||||||||||||||||||||
| Inactive | 0 | -4.05 | 2.7202 | 0.9497 | -18.9142 | -2.2922 | 4 | 0 0 0 0 0 | -14.0952 | -1.0768 | -4.0059 | -2.4795 | -5.6228 | -14.0952 | QC'd by Sytravon | |||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -7.7765 | -2.2569 | -3.9959 | -1.3451 | 0.1566 | -7.7765 | QC'd by Sytravon | |||||||||||||||||||||||||||||
| Inactive | 0 | -4 | 4.9549 | 0.7054 | -25.0658 | -0.5 | 4 | 0 0 0 0 0 | -17.5549 | -2.6051 | -3.8192 | -2.6993 | 6.0774 | -17.5549 | QC'd by Sytravon | |||||||||||||||||||||||||
| Inactive | 0 | -5.8 | 4.9549 | 0.4109 | -5.3905 | 4 | 4 | 0 0 0 0 0 | -2.4904 | 3.804 | 2.4492 | -14.0754 | 0.8551 | -2.4904 | QC'd by Sytravon |
| Inhibition at 26.1 uM |
|---|
| 1.22 |
| 1.22 |
| 1.22 |
| 1.22 |
| 1.21 |
| 1.21 |
| 1.21 |
| 1.21 |
| 1.21 |
| 1.21 |
| 1.21 |
| 1.21 |
| 1.21 |
| 1.21 |
| 1.21 |
| 1.21 |
| 1.21 |
| 1.21 |
| 1.21 |
| 1.21 |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0000073700 uM | Activity at 0.0000311978 uM | Activity at 0.0000755538 uM | Activity at 0.0001700784 uM | Activity at 0.0003537877 uM | Activity at 0.0007609388 uM | Activity at 0.00133 uM | Activity at 0.00267 uM | Activity at 0.00634 uM | Activity at 0.00855 uM | Activity at 0.017 uM | Activity at 0.041 uM | Activity at 0.071 uM | Activity at 0.179 uM | Activity at 0.354 uM | Activity at 0.663 uM | Activity at 1.576 uM | Activity at 1.933 uM | Activity at 5.110 uM | Activity at 9.286 uM | Activity at 17.35 uM | Activity at 44.46 uM | Activity at 93.38 uM | Activity at 162.7 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inactive | 0 | 0 | 0 | 4 | 0 | 6.9422 | 0 | 2.3728 | 0 | 0.4583 | 0 | 5.8022 | 9.8216 | 0 | 0 | 0 | QC'd by BIOMOL | |||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 0 | 0 | 0 | 0.7879 | 1.0771 | 0 | 0 | 4.0917 | 0 | 4.9983 | 0 | 0 | QC'd by BIOMOL | |||||||||||||||||||||
| Inactive | 0 | -7.3792 | 4.9549 | 0.4146 | 0.8611 | 5.5 | 4 | 0 0 0 0 0 0 0 0 0 0 0 | 1.8373 | 0 | 9.1117 | 5.5344 | 8.2389 | 0 | 0 | 2.3051 | 0 | 4.4881 | -0.9491 | 1.8373 | QC'd by BIOMOL | |||||||||||||||||
| Inactive | 0 | -5.1792 | 2.7202 | 0.8215 | -20.6639 | 2.5 | 4 | 0 0 0 0 0 0 0 0 0 0 1 | -6.0916 | 0 | -2.7966 | 0.2285 | 8.0815 | 2.583 | 3.7354 | 7.3202 | 1.7166 | -5.5554 | -18.8865 | -6.0916 | QC'd by BIOMOL | |||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 3.7495 | 7.2293 | 6.3714 | 5.6135 | 0 | 7.4829 | 0 | 1.6994 | 8.4113 | 0 | 0 | 3.7495 | QC'd by BIOMOL | |||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 6.3657 | 7.1953 | 7.3079 | 0 | 0 | 1.8794 | 5.9799 | 0 | 7.4799 | 0 | 0 | 6.3657 | QC'd by BIOMOL | |||||||||||||||||||||
| Inhibitor | 14.818 | 35.5149 | 21 | Partial curve; partial efficacy | -4.8292 | 3.0654 | 0.9214 | -31.0149 | 4.5 | -2.2 | 0 0 0 0 0 0 0 0 0 0 0 | -30.4291 | 5.7772 | 8.8781 | 3.6683 | 4.227 | 4.7222 | 8.0186 | 4.5719 | -4.2187 | 3.6532 | -13.8256 | -30.4291 | QC'd by BIOMOL | ||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 0 | 5.7817 | 5.8939 | 0 | 0 | 8.5995 | 0 | 0 | 6.0744 | 0 | 6.585 | 0 | QC'd by BIOMOL | |||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -2.1045 | 0 | 8.2523 | 0 | -2.1724 | 7.2216 | 0 | 7.3601 | -2.8223 | -6.1446 | 4.4899 | -2.1045 | QC'd by BIOMOL | |||||||||||||||||||||
| Inactive | 0 | -4.4292 | 4.9549 | 0.4721 | -18.445 | 1.5 | 4 | 0 0 0 0 0 0 0 0 0 0 0 | -13.2875 | 0 | 7.0161 | 4.5375 | 5.0482 | 0 | 0 | 5.2422 | -2.8732 | -8.9018 | 6.1541 | -13.2875 | QC'd by BIOMOL | |||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 9.4385 | 0 | 0 | 0 | 0.9321 | 0.5252 | 0 | 0 | 0 | 9.4894 | 0 | 9.4385 | QC'd by BIOMOL | |||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -1.1894 | 0 | 6.5585 | 0 | 4.486 | 0 | 0.5381 | 0 | 4.8639 | 3.4664 | 2.4738 | -1.1894 | QC'd by BIOMOL | |||||||||||||||||||||
| Inactive | 0 | -6.0792 | 4.9549 | 0.4047 | 5.5 | 0.1553 | 4 | 0 0 0 0 0 0 0 0 0 0 1 | 0 | 1.472 | 4.5108 | 0 | 0 | 0 | -2.7872 | 0 | 8.3864 | 0 | 8.0615 | 0 | QC'd by BIOMOL | |||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 0 | 0 | 0.7173 | 0.6679 | 2.5617 | 8.0704 | 0 | 0 | 9.8105 | 0 | 8.9731 | 0 | QC'd by BIOMOL | |||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 1.1339 | -2.3294 | 0 | 8.3935 | 0 | 0 | 9.7826 | 7.5714 | 6.4163 | 0 | 0 | 1.1339 | QC'd by BIOMOL | |||||||||||||||||||||
| Inactive | 0 | -9.0292 | 4.9549 | 0.3898 | 2 | -12.7871 | 4 | 0 0 0 0 0 0 0 0 0 0 1 | -4.0609 | -8.9892 | 3.4212 | -1.7578 | 7.1716 | 0.6137 | 5.2177 | 6.769 | 3.1957 | -7.1191 | -0.2144 | -4.0609 | QC'd by BIOMOL | |||||||||||||||||
| Inhibitor | 20.931 | 101.634 | 41 | Partial curve; high efficacy | -4.6792 | 4.095 | 0.99 | -99.5649 | 2.069 | -2.1 | 0 0 0 0 0 0 0 0 0 0 0 | -91.6804 | 5.2511 | 0 | 7.6294 | 0 | 3.8746 | 1.2696 | 0 | 0 | 0 | -20.7764 | -91.6804 | QC'd by BIOMOL | ||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 0 | 2.3204 | 0 | 2.2816 | 3.412 | 1.2564 | 1.6162 | 0 | 0 | 0 | 0.2287 | 0 | QC'd by BIOMOL | |||||||||||||||||||||
| Inactive | 0 | -4.5792 | 4.5045 | 0.7778 | -24.8885 | 3.5 | 4 | 0 0 0 0 0 0 0 0 0 0 0 | -22.8238 | 5.7426 | 8.6462 | 6.0217 | 3.7721 | 4.1656 | 9.0629 | 3.0606 | -1.1003 | -6.0335 | 1.2279 | -22.8238 | QC'd by BIOMOL | |||||||||||||||||
| Inhibitor | 33.1734 | 109.8312 | 10 | Single point of activity | -4.4792 | 4.9549 | 0.9783 | -109.3261 | 0.505 | -3 | 0 0 0 0 0 0 0 0 0 0 0 | -91.5629 | -0.0109 | -1.0575 | 1.0949 | 2.2698 | 9.4465 | -3.4594 | 0 | -7.4354 | 0 | 0 | -91.5629 | QC'd by BIOMOL |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0000073700 uM | Activity at 0.0000311978 uM | Activity at 0.0000755538 uM | Activity at 0.0001700784 uM | Activity at 0.0003537877 uM | Activity at 0.0007609388 uM | Activity at 0.00133 uM | Activity at 0.00267 uM | Activity at 0.00634 uM | Activity at 0.00855 uM | Activity at 0.017 uM | Activity at 0.041 uM | Activity at 0.071 uM | Activity at 0.179 uM | Activity at 0.354 uM | Activity at 0.663 uM | Activity at 1.576 uM | Activity at 1.933 uM | Activity at 5.110 uM | Activity at 9.286 uM | Activity at 17.35 uM | Activity at 44.46 uM | Activity at 93.38 uM | Activity at 162.7 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inhibitor | 4.1095 | 35.9554 | 21 | Complete curve; partial efficacy | -5.3862 | 1.4787 | 0.9847 | -33.4554 | 2.5 | -1.2 | 0 0 0 0 0 0 0 | -32.4628 | 2.1833 | 5.9706 | 0 | 0 | -5.6126 | -25.295 | -32.4628 | QC'd by Axon Medchem | ||||||||||||||||||
| Inhibitor | 14.581 | 34.6571 | 10 | Partial curve; partial efficacy; poor fit | -4.8362 | 2.3332 | 0.9403 | -32.1571 | 2.5 | -2.4 | 0 0 0 0 0 0 0 | -29.7143 | 0 | 0 | 0 | 7.4115 | 5.8195 | -6.9018 | -29.7143 | QC'd by Tocris | ||||||||||||||||||
| Inactive | 0 | -4.8362 | 1.8617 | 0.9256 | -16.6594 | 2.5 | 4 | 0 0 0 0 0 0 0 | -14.7161 | 2.6212 | 0.58 | 1.0251 | 6.2829 | 1.7864 | -3.3449 | -14.7161 | QC'd by Glixx | |||||||||||||||||||||
| Inhibitor | 1.636 | 66.1615 | 64 | Complete curve; partial efficacy | -5.7862 | 2.7202 | 0.9997 | -65.8116 | 0.3499 | -1.2 | 0 0 0 0 0 0 0 | -66.5014 | 0 | 0 | 0 | 0 | -37.9408 | -64.7373 | -66.5014 | QC'd by Glixx | ||||||||||||||||||
| Inactive | 0 | -4.6362 | 1.9673 | 0.7584 | -23.667 | -2.4671 | 4 | 0 0 0 0 0 0 0 | -19.3058 | -0.694 | -0.3893 | -3.2758 | -10.1148 | -2.3842 | -5.3061 | -19.3058 | QC'd by SIGMA | |||||||||||||||||||||
| Inactive | 0 | -4.7862 | 3.0654 | 1 | -20.0675 | 0 | 4 | 0 0 0 0 0 0 0 | -19.2229 | 0 | 0 | 0 | 0 | 0 | -2.9492 | -19.2229 | QC'd by Axon Medchem | |||||||||||||||||||||
| Inhibitor | 10.3225 | 47.8362 | 21 | Partial curve; partial efficacy | -4.9862 | 1.8851 | 0.9724 | -41.8362 | 6 | -2.2 | 0 0 0 0 0 0 0 | -38.781 | 9.2093 | 6.0955 | 0 | 7.7141 | 5.1385 | -14.8631 | -38.781 | QC'd by MedChem Express | ||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 6.0178 | 2.4248 | 6.4136 | 1.8969 | 0 | 6.2132 | 0 | 6.0178 | QC'd by Tocris | |||||||||||||||||||||||||
| Inhibitor | 29.0929 | 60.093 | 10 | Single point of activity | -4.5362 | 4.9549 | 1 | -60.0346 | 0.0584 | -3 | 0 0 0 0 0 0 0 | -54.4164 | 0 | 0 | 0 | 0 | 0 | 0 | -54.4164 | QC'd by Tocris | ||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -6.5432 | 0 | 0 | 0 | 0 | 0 | -1.4393 | -6.5432 | QC'd by Tocris | |||||||||||||||||||||||||
| Inhibitor | 16.3601 | 36.8511 | 10 | Partial curve; partial efficacy; poor fit | -4.7862 | 1.01 | 0.8986 | -32.3511 | 4.5 | -2.4 | 0 0 0 0 0 0 0 | -23.6259 | 8.7897 | 0 | 8.6961 | 0 | 0 | -7.2303 | -23.6259 | QC'd by Tocris | ||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 9.2406 | 0 | 0 | 1.7514 | 3.4967 | 0 | 7.926 | 9.2406 | QC'd by Glixx | |||||||||||||||||||||||||
| Inhibitor | 9.2 | 33.7152 | 10 | Partial curve; partial efficacy; poor fit | -5.0362 | 1.4163 | 0.9706 | -30.2152 | 3.5 | -2.4 | 0 0 0 0 0 0 0 | -27.2626 | 5.3147 | 2.6751 | 0 | 6.3042 | 0 | -12.9935 | -27.2626 | QC'd by Tocris | ||||||||||||||||||
| Inhibitor | 16.3601 | 52.6952 | 21 | Partial curve; partial efficacy | -4.7862 | 1.2876 | 0.9602 | -49.0421 | 3.653 | -2.2 | 0 0 0 0 0 0 0 | -37.7902 | 9.1493 | 0 | 0 | 5.1852 | 0 | -13.7877 | -37.7902 | QC'd by Tocris | ||||||||||||||||||
| Inactive | 0 | -4.7862 | 4.4495 | 0.9565 | -27.1196 | 3 | 4 | 0 1 0 0 0 0 0 | -26.7664 | 0 | -80.8549 | 5.9752 | 5.3786 | 0 | 0.9575 | -26.7664 | QC'd by Tocris | |||||||||||||||||||||
| Inhibitor | 0.5805 | 74.8185 | 26 | Complete curve; partial efficacy | -6.2362 | 3.6772 | 0.9839 | -72.7545 | 2.064 | -1.2 | 0 0 0 0 0 0 0 | -64.7375 | 1.5093 | 2.1407 | 2.7381 | -9.5317 | -70.5587 | -81.6221 | -64.7375 | QC'd by MedChem Express | ||||||||||||||||||
| Inhibitor | 18.3564 | 99.3241 | 10 | Single point of activity | -4.7362 | 3.6272 | 0.9917 | -97.7814 | 1.5427 | -3 | 0 0 0 0 0 0 0 | -94.2017 | 0 | 8.6442 | 0 | -1.0446 | 0 | -6.3447 | -94.2017 | QC'd by Tocris | ||||||||||||||||||
| Inhibitor | 29.0929 | 85.8302 | 10 | Single point of activity | -4.5362 | 4.9549 | 0.9979 | -84.331 | 1.4991 | -3 | 0 0 0 0 0 0 0 | -76.6062 | 0.5645 | 0 | 0 | 2.1433 | 2.1495 | 3.4024 | -76.6062 | QC'd by MedChem Express | ||||||||||||||||||
| Inhibitor | 12.9953 | 49.1721 | 21 | Partial curve; partial efficacy | -4.8862 | 2.2526 | 0.9678 | -45.6725 | 3.4996 | -2.2 | 0 0 0 0 0 0 0 | -42.1761 | 7.8315 | 0.285 | 0 | 1.2696 | 6.3138 | -12.2728 | -42.1761 | QC'd by Tocris | ||||||||||||||||||
| Inactive | 0 | -4.6862 | 1.8851 | 0.8683 | -38.0965 | -12.0167 | 4 | 0 0 0 0 0 0 0 | -33.4065 | -7.5139 | -13.5025 | -14.684 | -16.035 | -8.8732 | -16.7676 | -33.4065 | QC'd by Selleck |
| Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|
| Activity | = | 8.53 | % |
| Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|
| Activity | = | 24.33 | % |
| Standard Type | Activity Comment |
|---|---|
| Activity | Active |
| Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|
| Inhibition | = | 51.7 | % |
| Inhibition | <= | 30 | % |
| Inhibition | <= | 30 | % |
| Inhibition | <= | 30 | % |
| Inhibition | <= | 30 | % |
| Inhibition | = | 33 | % |
| Inhibition | <= | 30 | % |
| Inhibition | <= | 30 | % |
| Inhibition | = | 34.6 | % |
| Inhibition | <= | 30 | % |
| Inhibition | <= | 30 | % |
| Inhibition | <= | 30 | % |
| Standard Type | Activity Comment |
|---|---|
| Activity | Dose-dependent effect |
| Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|
| Inhibition | = | 92.1 | % |
| Inhibition | = | 50.2 | % |
| Inhibition | = | 55.3 | % |
| Inhibition | = | 63.7 | % |
| Inhibition | = | 43.4 | % |
| Inhibition | = | 50.5 | % |
| Inhibition | <= | 30 | % |
| Inhibition | = | 39.1 | % |
| Inhibition | = | 48.2 | % |
| Inhibition | = | 42.7 | % |
| Inhibition | = | 73.3 | % |
| Inhibition | = | 39.9 | % |
| Standard Type | Activity Comment |
|---|---|
| Activity | Active |
| Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|
| Inhibition | = | 40.8 | % |
| Inhibition | = | 51.5 | % |
| Inhibition | <= | 30 | % |
| Inhibition | = | 38.6 | % |
| Inhibition | = | 51.4 | % |
| Inhibition | = | 42.6 | % |
| Inhibition | = | 48 | % |
| Inhibition | = | 36.6 | % |
| Inhibition | = | 43.2 | % |
| Inhibition | = | 48.2 | % |
| Inhibition | = | 54.1 | % |
| Inhibition | = | 47.6 | % |
| Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|
| Inhibition | = | 36.9 | % |
| Inhibition | = | 49.9 | % |
| Inhibition | = | 55.7 | % |
| Inhibition | = | 44.2 | % |
| Inhibition | = | 40.3 | % |
| Inhibition | = | 51.2 | % |
| Inhibition | = | 33.4 | % |
| Inhibition | = | 38.2 | % |
| Inhibition | = | 51.7 | % |
| Inhibition | <= | 30 | % |
| Inhibition | = | 43 | % |
| Inhibition | = | 36.3 | % |
| Standard Type | Activity Comment |
|---|---|
| Activity | Dose-dependent effect |
| Standard Type | Activity Comment |
|---|---|
| Activity | Dose-dependent effect |
| Standard Type | Activity Comment |
|---|---|
| Activity | Not Active |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0000040000 uM | Activity at 0.0000163452 uM | Activity at 0.0000320000 uM | Activity at 0.0000806082 uM | Activity at 0.0001439601 uM | Activity at 0.0003895389 uM | Activity at 0.0007288991 uM | Activity at 0.00154 uM | Activity at 0.00290 uM | Activity at 0.00454 uM | Activity at 0.00833 uM | Activity at 0.021 uM | Activity at 0.041 uM | Activity at 0.095 uM | Activity at 0.199 uM | Activity at 0.321 uM | Activity at 0.689 uM | Activity at 1.028 uM | Activity at 2.684 uM | Activity at 5.101 uM | Activity at 10.05 uM | Activity at 24.85 uM | Activity at 39.21 uM | Activity at 78.39 uM | Activity at 125.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inactive | 0 | 0 | 0 | 4 | 58.4116 | 43.5916 | 25.8843 | 33.4207 | 9.1109 | 21.6395 | 45.6886 | 10.8911 | 28.3955 | 31.3127 | 38.9914 | 41.6558 | 58.4116 | QC'd by Sytravon | |||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -12.6805 | -10.7548 | -9.5107 | -10.6418 | -15.9997 | -12.6805 | QC'd by Sytravon | ||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -7.1462 | -9.2235 | -11.8601 | -6.118 | -12.2196 | -7.1462 | QC'd by Sytravon | ||||||||||||||||||||||||||||
| Inactive | 0 | -4.75 | 4.9549 | 0.6661 | -22.0013 | -2 | 4 | 0 0 0 0 0 | -18.751 | -10.987 | -0.9935 | 2.356 | 1.2583 | -18.751 | QC'd by Sytravon | ||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -11.1249 | -10.2692 | -11.5229 | -11.032 | -13.325 | -11.1249 | QC'd by Sytravon | ||||||||||||||||||||||||||||
| Inactive | 0 | -4.8 | 1.8851 | 0.5555 | -23.9168 | -5.4088 | 4 | 0 0 0 0 0 | -18.264 | -13.0121 | -2.8407 | -6.6548 | -7.1687 | -18.264 | QC'd by Sytravon | ||||||||||||||||||||||||
| Inactive | 0 | -6.35 | 4.9549 | 0.9083 | -3.1815 | -14.9283 | 4 | 0 0 0 0 1 | -10.2909 | -13.1276 | -17.0236 | -1.4012 | -4.6174 | -10.2909 | QC'd by Sytravon | ||||||||||||||||||||||||
| Inactive | 0 | -5.95 | 0.4 | 0.9812 | -20.7272 | -0.9942 | 4 | 0 0 0 0 0 | -16.0227 | -4.9952 | -8.1266 | -9.7286 | -14.3153 | -16.0227 | QC'd by Sytravon | ||||||||||||||||||||||||
| Inactive | 0 | -6.5 | 4.9549 | 0.6409 | -9.2158 | -16.6011 | 4 | 0 0 0 0 1 | -12.7654 | -16.3342 | -16.1896 | -6.0131 | -13.084 | -12.7654 | QC'd by Sytravon | ||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 1.975 | 2.6103 | 3.4198 | -3.4748 | 1.7624 | 1.975 | QC'd by Sytravon | ||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -8.2223 | -0.1456 | -4.3339 | -1.582 | -3.6253 | -8.2223 | QC'd by Sytravon | ||||||||||||||||||||||||||||
| Inactive | 0 | -7.25 | 4.9549 | 0.602 | -10.0715 | 2 | 4 | 0 0 0 0 0 | -12.6011 | 0.2325 | -14.2262 | -4.5441 | -8.7364 | -12.6011 | QC'd by Sytravon | ||||||||||||||||||||||||
| Inactive | 0 | -4.75 | 4.5045 | 0.9809 | -24.6554 | -10.8442 | 4 | 0 0 0 0 0 | -22.2129 | -9.8702 | -10.3098 | -11.7375 | -10.6121 | -22.2129 | QC'd by Sytravon | ||||||||||||||||||||||||
| Inactive | 0 | -4.75 | 4.9549 | 0.8409 | -13.5514 | 2 | 4 | 0 0 0 0 0 | -11.2928 | -1.9276 | 4.6106 | 1.3336 | 4.0275 | -11.2928 | QC'd by Sytravon | ||||||||||||||||||||||||
| Inactive | 0 | -5.2 | 0.5 | 0.9077 | -28.8252 | -9.4452 | 4 | 0 0 0 0 0 | -23.1876 | -10.7877 | -12.0613 | -16.7104 | -16.3414 | -23.1876 | QC'd by Sytravon | ||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -18.3436 | -16.2788 | -21.7212 | -19.8613 | -16.6894 | -18.3436 | QC'd by Sytravon | ||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -5.4025 | -9.518 | -0.1694 | 0.2848 | -4.8162 | -5.4025 | QC'd by Sytravon | ||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -23.1229 | -14.0834 | -13.5556 | -16.7644 | -18.8145 | -23.1229 | QC'd by Sytravon | ||||||||||||||||||||||||||||
| Inactive | 0 | -4.95 | 3.2975 | 0.9426 | -35.5663 | -15.2262 | 4 | 0 0 0 0 0 | -34.2687 | -12.6885 | -18.3414 | -14.0693 | -16.4909 | -34.2687 | QC'd by Sytravon | ||||||||||||||||||||||||
| Inactive | 0 | -4.75 | 4.9549 | 0.7952 | -15.6253 | -4.8932 | 4 | 0 0 0 0 0 | -13.8544 | -4.3645 | -8.5252 | -3.661 | -3.9903 | -13.8544 | QC'd by Sytravon |
| Standard Type | Activity Comment |
|---|---|
| Activity | Active |
| Standard Type | Activity Comment |
|---|---|
| Activity | Active |
| Standard Type | Activity Comment |
|---|---|
| Activity | Not Active |
| Activity | Not Active |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|---|
| 18 | GI50 | = | 18000 | nM |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|---|
| 16 | GI50 | = | 16000 | nM |
| Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|
| Activity | = | 11.3 | day |
| Activity | = | 8.2 | day |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|---|
| 15 | GI50 | = | 15000 | nM |
| Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|
| Activity | = | -0.004 | mg/mg/day |
| Activity | = | -0.01 | mg/mg/day |
| Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|
| Activity | = | 56.6 | % |
| Activity | = | 73.3 | % |
| Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|
| Activity | = | 48.44 | % |
| Activity | = | 70 | % |
| Activity | = | 141.67 | % |
| Activity | = | 58.49 | % |
| Activity | = | 64.78 | % |
| Activity | = | 52.2 | % |
| Activity | = | 62.16 | % |
| Activity | = | 100 | % |
| Activity | = | 36.36 | % |
| Activity | = | 24.73 | % |
| Activity | = | 12 | % |
| Activity | = | 45.15 | % |
| Activity | = | 60.45 | % |
| Activity | = | 14.91 | % |
| Activity | = | 92.19 | % |
| Activity | = | 79.69 | % |
| Activity | = | 22.91 | % |
| Activity | = | 113.51 | % |
| Activity | = | 34.7 | % |
| Activity | = | 40.3 | % |
| Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|
| Activity | = | -8.908 | % |
| Activity | = | -66.1 | % |
| Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|
| Activity | = | 71.77 | % |
| Activity | = | 76.81 | % |
| Activity | = | 234.78 | % |
| Activity | = | 51.41 | % |
| Activity | = | 46.89 | % |
| Activity | = | 71.19 | % |
| Activity | = | 2.78 | % |
| Activity | = | 91.35 | % |
| Activity | = | 37.3 | % |
| Activity | = | 20 | % |
| Activity | = | 25.95 | % |
| Activity | = | 38.56 | % |
| Activity | = | 75.42 | % |
| Activity | = | 55.14 | % |
| Activity | = | 63.71 | % |
| Activity | = | 1.61 | % |
| Activity | = | 25.95 | % |
| Activity | = | 98.61 | % |
| Activity | = | 34.75 | % |
| Activity | = | 47.03 | % |
| Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|
| Activity | = | 0.058 | mg/mg/day |
| Activity | = | 0.017 | mg/mg/day |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|---|
| 10 | IC50 | > | 10000 | nM |
| 10 | IC50 | > | 10000 | nM |
| 10 | IC50 | > | 10000 | nM |
| 10 | IC50 | > | 10000 | nM |
| 10 | IC50 | > | 10000 | nM |
| 10 | IC50 | > | 10000 | nM |
| 10 | IC50 | > | 10000 | nM |
| 10 | IC50 | > | 10000 | nM |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|---|
| 10 | IC50 | > | 10000 | nM |
| 10 | IC50 | > | 10000 | nM |
| 10 | IC50 | > | 10000 | nM |
| 10 | IC50 | > | 10000 | nM |
| 10 | IC50 | > | 10000 | nM |
| 10 | IC50 | > | 10000 | nM |
| 10 | IC50 | > | 10000 | nM |
| 10 | IC50 | > | 10000 | nM |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|---|
| 10 | IC50 | > | 10000 | nM |
| 10 | IC50 | > | 10000 | nM |
| 10 | IC50 | > | 10000 | nM |
| 10 | IC50 | > | 10000 | nM |
| 10 | IC50 | > | 10000 | nM |
| 10 | IC50 | > | 10000 | nM |
| 10 | IC50 | > | 10000 | nM |
| 10 | IC50 | > | 10000 | nM |
| Activation at 11.2 uM |
|---|
| 25.9791 |
| 24.6001 |
| 23.5536 |
| 22.7312 |
| 22.7177 |
| 22.1764 |
| 22.1331 |
| 21.3196 |
| 20.9399 |
| 20.5357 |
| 19.9724 |
| 19.7958 |
| 19.6966 |
| 19.0437 |
| 18.6511 |
| 18.5926 |
| 18.5486 |
| 18.5244 |
| 18.4073 |
| 18.3393 |
| Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|
| Activity | = | 86.1 | % |
| Activity | = | 93.4 | % |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|---|
| 16 | GI50 | = | 16000 | nM |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|---|
| 10 | IC50 | > | 10000 | nM |
| 10 | IC50 | > | 10000 | nM |
| 10 | IC50 | > | 10000 | nM |
| 10 | IC50 | > | 10000 | nM |
| 10 | IC50 | > | 10000 | nM |
| 10 | IC50 | > | 10000 | nM |
| 10 | IC50 | > | 10000 | nM |
| 10 | IC50 | > | 10000 | nM |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|---|
| 16 | GI50 | = | 16000 | nM |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|---|
| 10 | IC50 | > | 10000 | nM |
| 10 | IC50 | > | 10000 | nM |
| 10 | IC50 | > | 10000 | nM |
| 10 | IC50 | > | 10000 | nM |
| 10 | IC50 | > | 10000 | nM |
| 10 | IC50 | > | 10000 | nM |
| 10 | IC50 | > | 10000 | nM |
| 10 | IC50 | > | 10000 | nM |
| Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|
| Inhibition | = | 72.6 | % |
| Inhibition | <= | 30 | % |
| Inhibition | = | 33.4 | % |
| Inhibition | <= | 30 | % |
| Inhibition | <= | 30 | % |
| Inhibition | = | 34.2 | % |
| Inhibition | <= | 30 | % |
| Inhibition | <= | 30 | % |
| Inhibition | = | 35.5 | % |
| Inhibition | <= | 30 | % |
| Inhibition | <= | 30 | % |
| Inhibition | <= | 30 | % |
| Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|
| Inhibition | = | 69.5 | % |
| Inhibition | <= | 30 | % |
| Inhibition | = | 33.2 | % |
| Inhibition | <= | 30 | % |
| Inhibition | <= | 30 | % |
| Inhibition | = | 33.5 | % |
| Inhibition | <= | 30 | % |
| Inhibition | <= | 30 | % |
| Inhibition | = | 35.1 | % |
| Inhibition | <= | 30 | % |
| Inhibition | <= | 30 | % |
| Inhibition | <= | 30 | % |